Publication | Open Access
FeSe<sub>2</sub>‐Decorated Bi<sub>2</sub>Se<sub>3</sub> Nanosheets Fabricated via Cation Exchange for Chelator‐Free <sup>64</sup>Cu‐Labeling and Multimodal Image‐Guided Photothermal‐Radiation Therapy
257
Citations
43
References
2016
Year
Multifunctional theranostic agents have become rather attractive to realize image-guided combination cancer therapy. Herein, we develop a novel method to synthesize Bi<sub>2</sub>Se<sub>3</sub> nanosheets decorated with mono-dispersed FeSe<sub>2</sub> nanoparticles (FeSe<sub>2</sub>/Bi<sub>2</sub>Se<sub>3</sub>) for tetra-modal image-guided combined photothermal & radiation tumor therapy. Interestingly, upon addition of Bi(NO<sub>3</sub>)<sub>3</sub>, pre-made FeSe<sub>2</sub> nanoparticles via cation exchange would be gradually converted into Bi<sub>2</sub>Se<sub>3</sub> nanosheets, on which remaining FeSe<sub>2</sub> nanoparticles are decorated. The yielded FeSe<sub>2</sub>/Bi<sub>2</sub>Se<sub>3</sub> composite-nanostructures were then modified with polyethylene glycol (PEG). Taking advantages of the high r<sub>2</sub> relaxivity of FeSe<sub>2</sub>, the X-ray attenuation ability of Bi<sub>2</sub>Se<sub>3</sub>, the strong near-infrared (NIR) optical absorbance of the whole nanostructure, as well as the chelate-free radiolabeling of <sup>64</sup>Cu on FeSe<sub>2</sub>/Bi<sub>2</sub>Se<sub>3</sub>-PEG, <i>in vivo</i> magnetic resonance (MR)/computer tomography (CT)/photoacoustic (PA)/position emission tomography (PET) multimodal imaging was carried out, revealing efficient tumor homing of FeSe<sub>2</sub>/Bi<sub>2</sub>Se<sub>3</sub>-PEG after intravenous injection. Utilizing the intrinsic physical properties of FeSe<sub>2</sub>/Bi<sub>2</sub>Se<sub>3</sub>-PEG, <i>in vivo</i> photothermal & radiation therapy to achieve synergistic tumor destruction was then realized, without causing obvious toxicity to the treated animals. Our work presents a unique method to synthesize composite-nanostructures with highly integrated functionalities, promising not only for nano-biomedicine, but also potentially for other different nanotechnology fields.
| Year | Citations | |
|---|---|---|
Page 1
Page 1